Abstract:This report describes the synthesis of two cyclic RGD (Arg-Gly-Asp) conjugates, HYNIC-2PEG(4)-dimer (HYNIC = 6-hydrazinonicotinyl; 2PEG(4)-dimer = E[PEG(4)-c(RGDfK)](2); and PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid) and HYNIC-3PEG(4)-dimer (3PEG(4)-dimer = PEG(4)-E[PEG(4)-c(RGDfK)](2)), and evaluation of their Tc-99m complexes [Tc-99m(HYNIC-2PEG(4)-dimer)(tricine)(TPPTS)] (Tc-99m-2PEG(4)-dimer: TPPTS = trisodium triphenylphosphine-3,3',3 ''-trisulfonate) and [Tc-99m(HYNIC-3PEG(4)-dimer)(tricine)(TPPTS)] (Tc-99m-3PEG(4)-dimer) as novel radiotracers for imaging integrin alpha(v)beta(3) expression in athymic rude mice bearing U87MG glioma and MDA-MB-435 breast cancer xenografts. The integrin alpha(v)beta(3) binding affinities of RGD peptides were determined by competitive displacement of I-125-c(RGDyK) on U87MG glioma cells. It was found that the two PEG4 linkers between RGD motifs in HYNIC-2PEG(4)-dimer (IC50 = 2.8 +/- 0.5 nM) and HYNIC-3PEG(4)-dimer (IC50 = 2.4 +/- 0.7 nM) are responsible for their higher integrin alpha(v)beta(3) binding affinity than that of HYNIC-PEG(4)-dimer (PEG(4)-dimer = PEG(4)-E[c(RGDfK)](2); IC50 = 7.5 +/- 2.3 nM). Addition of extra PEG(4) linker in HYNIC-3PEG(4)-dimer has. little impact on integrin alpha(v)beta(3) binding affinity. Tc-99m-2PEG(4)-dimer and Tc-99m-3PEG(4)-dimer were prepared in high yield with >95% radiochemical purity and the specific activity of > 10 CI/mu mol. Biodistribution :studies clearly demonstrated that PEG(4) linkers are particularly useful for improving the tumor uptake and clearance kinetics of 99mTc-2PEG4-dimer and Tc-99m-3PEG(4)-dimer from noncancerous organs. It was also found that there was a linear relationship between the tumor size and radiotracer tumor uptake expressed as %ID (percentage of the injected dose) in U87MG glioma and MDA-MB-435 breast tumor models. The blocking experiment showed that the tumor uptake of Tc-99m-2PEG(4)-dimer is integrin alpha(v)beta(3)-mediated. In the metabolism study, Tc-99m-2PEG(4)-dimer had high metabolic stability during its excretion from renal and hepatobiliary routes. Tc-99m-3PEG(4)-dimer also remained intact during thee excretion from the renal route, but, had similar to 30% metabolism during the excretion from the hepatobiliary route. Planar imaging studies in U87MG glioma and MDA-MB-435 breast tumor models showed that the tumors of similar to 5 mm in diameter could be readily visualized with excellent contrast. Thus, Tc-99m-3PEG(4)-dimer is a very promising radiotracer for the early detection of integrin alpha(v)beta(3)-positive tumors, and may have the potential for noninvasive monitoring of tumor growth or treatment efficacy.

Preparation of 99Tcm labeled cyclic RGDfK dimer and its in vitro and in vivo evaluation

Imaging of 99Tcm-Labeled New Cyclic RGDfK Dimer in Nude Mice Bearing U87MG Human Glioma Xenografts

Imaging of 99Tcm-Cycllc RGD Tetramer in Nude Mice Bearing U87MG Human Glioma Xenografts

<SUP>68</SUP>Ga-Labeled GX1 Dimer: A Novel Probe for PET/Cerenkov Imaging Targeting Gastric Cancer

In Vivo and in Vitro Studies of 99Tcm-3P-rgd2 Targeting Integrin Αvβ3 in Lung Cancer

131)I Labeling and Bioactivity Evaluation of a Novel RGD Dimer Targeted to Integrin Αvβ3 Receptor

A New Cyclic RGD Peptide Dimer for Integrin Αvβ3 Imaging.

Improving Tumor-Targeting Capability and Pharmacokinetics of 99Mtc-Labeled Cyclic RGD Dimers with PEG4 Linkers

One-step Radiosynthesis of 18F-Alf-nota-rgd2 for Tumor Angiogenesis PET Imaging

Preparation of 90Y-Labeled Different Cyclic RGD Peptides and Evaluation in Nude Mice Bearing Human Glioma Xenografts

Studies on distribution and imaging of 131I-labelled RGD peptide in mice bearing tumors

Improving Tumor Uptake and Excretion Kinetics of 99Mtc-Labeled Cyclic Arginine-Glycine-aspartic (RGD) Dimers with Triglycine Linkers.

Evaluation of a 99Mtc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin Αvβ3-Positive Breast Cancer

A Novel Integrinαvβ3-Targeted Isodgr Probe for SPECT/CT Imaging of Glioma

18F Labeled RGD‐A7R Peptide for Dual Integrin and VEGF‐targeted Tumor Imaging in Mice Bearing U87MG Tumors

68 Ga-labeled Cyclic RGD Dimers with Gly 3 and PEG 4 Linkers: Promising Agents for Tumor Integrin Α V Β 3 PET Imaging

Design, Activity Determination and 99mtc Labeling of Cyclic RGD Dimer for Targeting Integrin Αvβ3

Tumor uptake of the RGD dimeric probe99mTc-G3-2P 4-RGD2 is correlated with integrin αv/β 3 expressed on both tumor cells and neovasculature

Synthesis and preclinical evaluation of a heterodimeric radioligand targeting fibroblast activation protein and integrin-αvβ3

[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor

Preliminary study of molecular imaging of human hepatocellular carcinoma xenograft with Gd-based MR probe containing arginine-glycine-aspartic acid chelate